Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes - Wikidata - awgldk - TriplyDB

Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes

Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes

http://www.wikidata.org/entity/Q33804692

about

The endothelium abridges insulin resistance to premature aging Reactive oxygen species adversely impacts bone marrow microenvironment in diabetes Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis.Glucose challenge increases circulating progenitor cells in Asian Indian male subjects with normal glucose tolerance which is compromised in subjects with pre-diabetes: A pilot study.Circulating vascular progenitor cells and central arterial stiffness in polycystic ovary syndrome.The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation.Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration Immunolocalization of CD34 Positive Progenitor Cells in Diabetic and Non Diabetic Periodontitis Patients - A Comparative Study.Cell-based therapies for diabetic complications.Recent advances in the diagnosis and treatment of acute myocardial infarction Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus Decreased pre-surgical CD34+/CD144+ cell number in patients undergoing coronary artery bypass grafting compared to coronary artery disease-free valvular patients.Decreased levels of circulating CD34(+) cells are associated with coronary heart disease in Japanese patients with type 2 diabetes.It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications.Exposure to ambient air fine particulate matter prevents VEGF-induced mobilization of endothelial progenitor cells from the bone marrow.Rapid assay of stem cell functionality and potency using electric cell-substrate impedance sensing Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome.A novel autologous cell-based therapy to promote diabetic wound healing.Diabetes impairs stem cell and proangiogenic cell mobilization in humans.Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway Exercise-induced endothelial progenitor cell mobilization is attenuated in impaired glucose tolerance and type 2 diabetes Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model Depletion of circulating progenitor cells precedes overt diabetes: a substudy from the VA enhanced fitness trial.Bone marrow mononuclear cell angiogenic competency is suppressed by a high-salt diet.Obesity paradox does exist Emerging roles of hematopoietic cells in the pathobiology of diabetic complications.Endothelial dysfunction in diabetes: the role of reparatory mechanisms.Mobilization of stem and progenitor cells in cardiovascular diseases.Bone marrow stem cell abnormality and diabetic complications.Endothelial progenitor cells in diabetes mellitus.A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications.Stem cells for cardiac repair: problems and possibilities.Advances in stem cell mobilization.The endothelium in diabetic nephropathy.Stem cell therapies in the treatment of diabetic retinopathy and keratopathy.Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes.Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice.Status of stem cells in diabetic nephropathy: predictive and preventive potentials.

P2860

Q24605364-F9D99016-5BF4-4318-9DE3-69965FD8D851 Q27002524-116EB0B2-7D8B-4AF0-98B3-3BB9C6C80528 Q33633882-957FA720-2917-4E7A-8A0A-9B8F61DB2981 Q33789628-89ACA04B-003F-41C9-9283-EA1886947B22 Q33927310-75DC5AD4-1DB5-48DC-8C45-7877C280190D Q33932817-E7C8BE0B-E02D-4B4B-957B-714ED5DE7326 Q34355975-B85E48F6-2A4E-40CF-A5E2-88490B6FE388 Q34446306-DF1AD957-D36F-49C5-A91F-B61CCABD70A4 Q34718887-B7D0D77C-823E-4E0B-8BC5-14D23E9FD5B6 Q34910411-29759B39-B302-4DE2-9B4D-0E8EBBF6ED36 Q35070554-1541C004-B15F-47D4-B936-C76F5AC8F4CE Q35626702-F96980B2-1CE6-499B-BC10-2B17B6DF3F5B Q35672600-A811ED25-1D39-48DB-9EFC-C518F88118A0 Q35712258-97F289CB-211B-4A2E-9DF6-D1501CA6CD27 Q35879342-4A7307EF-364C-4C7E-BD53-1FE42BF8E005 Q35882798-834E8148-98AF-4871-8A5E-0E89147AAE8F Q36064727-44AA7F65-1595-45DB-B981-CEB42A5E4CE6 Q36126357-2E5B00CE-0857-4ED5-B793-D9A1107F6AE3 Q36242530-C65942BF-5557-4B93-B072-B9A57A80832B Q36301623-ED689955-F9A5-4112-8DE5-D683C578EDCB Q36720330-40A7EA35-9F77-4A7A-B86F-5B5521055408 Q36739740-7F4614F9-F260-4DC8-A872-C9FB5D13CBED Q37139734-7D282ED5-81AE-4BDF-B439-62EAB1424454 Q37172543-531F8E2D-CA17-4959-BBA0-0AC1DEB44602 Q37418276-D3B03E78-893B-4BB5-B1C2-E89C0AECD4B0 Q37575326-98CB0155-E392-4FA3-90D6-D3753CA78BF9 Q37577182-A9DB5B04-A879-4695-BC5D-99DA5AD77185 Q37684896-2961406A-1311-43A7-9564-76ABCCEDDBDD Q37869700-6107235C-7D0F-42BF-B804-9083B7C235AE Q37905521-059D56B5-8443-45EC-B8AE-0743D5610EFC Q37995119-F69C87B2-3622-4232-8190-F283E37EC632 Q38001402-A5BAF2DF-F374-4AEB-9B1B-FD7C88495364 Q38156645-83078D2F-3237-4DA4-AD71-7BF9AF2BC7DA Q38158218-86E3B148-19D1-4294-8C85-5C4D5B8953C9 Q38183225-0883955D-762C-4E3D-A103-3CD9D817CB62 Q38195528-C957DB7B-2950-40DF-A049-522100A44CF1 Q38603660-2C3C5ED7-3082-4D7B-A626-EE1A75E6E255 Q38843000-7BCA79E6-CB9D-4142-8527-20CCCFABC41E Q39963297-E0849BDD-6B37-412F-BA17-4D40C094EE5D Q41296335-BCD806B8-75EE-40D8-85D1-A002FC61E036

P2860

Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes

http://www.wikidata.org/entity/Q33804692

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Time course and mechanisms of ...... ral history of type 2 diabetes

@ast

Time course and mechanisms of ...... ral history of type 2 diabetes

@en

type

label

Time course and mechanisms of ...... ral history of type 2 diabetes

@ast

Time course and mechanisms of ...... ral history of type 2 diabetes

@en

prefLabel

Time course and mechanisms of ...... ral history of type 2 diabetes

@ast

Time course and mechanisms of ...... ral history of type 2 diabetes

@en

P1433

Q33804692-2A0C05A8-DA14-4DB8-8088-760A9AD29F9D

P1476

Q33804692-9A384241-EBC4-457C-A928-3CA949197F21

P2093

Q33804692-0BF22805-114C-4390-B927-9EC1F145C82C

Q33804692-0E414264-9E92-4DAA-97D6-F22DCC321033

Q33804692-BA52A9E2-D5B4-48CA-BD4B-AA316B98F2C4

Q33804692-DF476376-6E90-4110-A7CD-6559A36D0445

Q33804692-EDFCD166-AC38-4523-B9E7-2942AD055A26

P2860

Q33804692-02039F63-08A6-4B9F-9F76-B4249417E50D

Q33804692-059AA881-A053-4AA5-9BC7-2FE052858CA0

Q33804692-11A89CDC-F558-4C80-B93C-7057A39826D5

Q33804692-25BB4F3D-1FEE-475A-9D42-5DAB082A7E25

Q33804692-27AFF565-80A5-43C7-98B4-B9DA5DBBA668

Q33804692-40E1C8DD-2E0B-4EDA-B202-5CB616A15D3D

Q33804692-6CB2D864-2BB4-49D0-8FA7-088686F82E31

Q33804692-76A0F73E-93D9-47AD-A7BF-CD7C0AE839A3

Q33804692-78E23A02-AE81-43FB-9F33-12E7BB34FE2C

Q33804692-8902D2C8-2BEB-488E-B05D-ACF7318416C9

P304

Q33804692-63386981-6D23-4C48-90BE-6CD0E38C799D

P31

Q33804692-9486281C-68F3-4C34-9E1D-0A36F279CDDA

P356

Q33804692-EB89368A-F3D0-4838-BE84-CC31C89595F0

P407

Q33804692-2D767A33-350D-413B-83C7-7A8AD1B46278

P433

Q33804692-D8C8E14D-49F2-4478-AB0E-5EFAD4FD5446

P478

Q33804692-BF0A38B9-1E56-430A-B1DB-D0284F88EAC7

P50

Q33804692-5C3313A0-0983-4E20-8862-34598677E825

Q33804692-7BD902F3-40AA-4748-A060-4DC9C7529908

Q33804692-944791A9-9C9E-4596-90D3-24D415FF695F

Q33804692-CA46EB0B-F5A0-4B29-9D06-CBB3B219671B

P577

Q33804692-8BC3CB42-827B-410B-9A33-C52E9CCE69A8

P5875

Q33804692-99FA3367-D96B-4492-947E-0CE84D956DC5

P698

Q33804692-B6A0B256-D21E-4269-A846-B3CC51871152

P921

Q33804692-D4A33EB1-ECBF-4892-B550-C7CECFF769C9

P932

Q33804692-A44A3BDB-CBFE-4D28-AD1B-4A526A8FED53

P356

P1433

P1476

Time course and mechanisms of ...... ral history of type 2 diabetes

@en

P2093

Angelo Avogaro

http://www.w3.org/2001/XMLSchema#string

Antonio Tiengo

http://www.w3.org/2001/XMLSchema#string

Elisa Boscaro

http://www.w3.org/2001/XMLSchema#string

Florian Seeger

http://www.w3.org/2001/XMLSchema#string

Saula de Kreutzenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating endothelial progenitor cells and cardiovascular outcomes

Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock

Glycation products and the pathogenesis of diabetic complications.

Endothelial progenitor cells: characterization and role in vascular biology.

Endothelial dysfunction in type 2 diabetes mellitus.

Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling.

Significance of endothelial progenitor cells in subjects with diabetes.

Endothelial progenitor cells in the natural history of atherosclerosis.

Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau.

Mechanisms and significance of progenitor cell reduction in the metabolic syndrome.

P304

1097-1102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-1999

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Stefanie Dimmeler

Gian Paolo Fadini

P577

2010-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41424705

http://www.w3.org/2001/XMLSchema#string

P698

20150295

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2858183

http://www.w3.org/2001/XMLSchema#string